NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection targets bladder tumors in early trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for people with a type of bladder cancer that hasn't spread into the muscle layer. The drug is injected directly into the tumor, sometimes with a laser, to see if it's safe and possible to do. Abo…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug cocktail aims to fight tough bladder cancer without surgery
Disease control Recruiting nowThis study tests two drugs, durvalumab and monalizumab, given together monthly for up to a year in people with a type of bladder cancer that hasn't been cured by standard therapy. The goal is to see if the combination can make the cancer disappear completely. About 60 adults with…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: John Sfakianos • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Immunotherapy may replace chemo for bladder cancer patients
Disease control Recruiting nowThis study compares two treatments for a type of bladder cancer that hasn't spread into the muscle. One group gets standard chemotherapy plus radiation, while the other gets an immunotherapy drug (pembrolizumab) plus radiation. The goal is to see which approach better prevents th…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Could one surgery be enough? new trial aims to cut unnecessary procedures for bladder cancer patients
Disease control Recruiting nowThis study compares a newer, single surgery using special dye and light (PDD-TURBT) against the standard approach of two surgeries for early-stage bladder cancer. About 112 adults with non-muscle invasive bladder cancer will be randomly assigned to either the new single-surgery m…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
New DNA test may spot hidden bladder cancer before surgery
Diagnosis Recruiting nowThis study is testing whether a combination of blood and urine DNA tests can detect muscle-invasive bladder cancer that standard scopes might miss before bladder removal surgery. About 92 adults scheduled for cystectomy will provide samples to see if the test accurately predicts …
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated May 26, 2026 11:53 UTC
-
Can a prostate cancer drug change bladder cancer cell proteins?
Knowledge-focused Recruiting nowThis early-stage trial studies whether bicalutamide, a drug that blocks male hormones, can change a protein called EGFR in bladder cancer cells. About 80 adult men with non-muscle invasive bladder cancer will either receive the drug or no study drug. The goal is to understand how…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated May 26, 2026 11:53 UTC